Zivo Bioscience, Inc. (ZIVO)
3.30
-0.30
(-8.33%)
USD |
OTCM |
Sep 25, 16:00
Zivo Bioscience Enterprise Value : 14.37M for Sept. 25, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 25, 2026 | 14.37M |
| September 24, 2026 | 15.63M |
| September 23, 2026 | 15.63M |
| September 22, 2026 | 15.42M |
| September 21, 2026 | 13.94M |
| September 18, 2026 | 13.94M |
| September 17, 2026 | 13.88M |
| September 16, 2026 | 14.58M |
| September 15, 2026 | 17.74M |
| September 14, 2026 | 17.74M |
| September 11, 2026 | 17.74M |
| September 10, 2026 | 15.63M |
| September 09, 2026 | 13.58M |
| September 08, 2026 | 13.58M |
| September 04, 2026 | 15.63M |
| September 03, 2026 | 15.63M |
| September 02, 2026 | 17.11M |
| September 01, 2026 | 17.11M |
| August 31, 2026 | 18.45M |
| August 28, 2026 | 18.45M |
| August 27, 2026 | 18.45M |
| August 26, 2026 | 18.45M |
| August 25, 2026 | 18.45M |
| August 24, 2026 | 18.45M |
| August 21, 2026 | 18.37M |
| Date | Value |
|---|---|
| August 20, 2026 | 17.11M |
| August 19, 2026 | 17.11M |
| August 18, 2026 | 17.53M |
| August 17, 2026 | 17.53M |
| August 14, 2026 | 18.54M |
| August 13, 2026 | 18.54M |
| August 12, 2026 | 18.54M |
| August 11, 2026 | 18.54M |
| August 10, 2026 | 17.40M |
| August 07, 2026 | 17.40M |
| August 06, 2026 | 17.40M |
| August 05, 2026 | 17.32M |
| August 04, 2026 | 17.32M |
| August 03, 2026 | 17.32M |
| July 31, 2026 | 17.32M |
| July 30, 2026 | 17.32M |
| July 29, 2026 | 17.32M |
| July 28, 2026 | 17.32M |
| July 27, 2026 | 21.53M |
| July 24, 2026 | 21.53M |
| July 23, 2026 | 21.53M |
| July 22, 2026 | 17.32M |
| July 21, 2026 | 17.32M |
| July 20, 2026 | 17.65M |
| July 17, 2026 | 17.91M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| PMGC Holdings, Inc. | -4.273M |
| Shonghoya Intl Group, Inc. | 33.64M |
| Cordyceps Sunshine Biotech Holdings Co., Ltd. | -- |
| Arcadia Biosciences, Inc. | -3.507M |
| CCA Industries, Inc. | 3.803M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.5125M |
| Total Expenses (Quarterly) | 0.5125M |
| EPS Diluted (Quarterly) | -0.1235 |
| Earnings Yield | -42.61% |
| Normalized Earnings Yield | -42.64 |